Mirum Pharmaceuticals, Inc. MIRM Net Investment in Lease
Net Investment in Lease at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s net investment in lease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s net investment in lease?
- Mirum Pharmaceuticals, Inc. (MIRM) reported net investment in lease of $12.65M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s net investment in lease changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s net investment in lease increased by 65.0% year-over-year, from $7.66M to $12.65M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s net investment in lease?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s net investment in lease has grown at a 35.0% compound annual growth rate (CAGR), from $1.95M to $8.74M.